K243981

Substantially Equivalent

Hexoskin Medical System (7100-00016)

Applicant: Carre Technologies, Inc.
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2024-12-23
Decision date: 2025-11-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montreal, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.